2D-DIGE analysis revealed reduced cytokeratin signaling in placenta with preeclampsia

Signal Transduction

Volumn 6, Issue 3, 2006, Pages 190-197

  Hass, Ralf ^a   Kirchner, Markus ^a   Hollwitz, Bettina ^a   Scharf, Alexander ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

2D DIGE; Cytokeratins; Placenta; Preeclampsia

Indexed keywords

BETA ACTIN; CYTOKERATIN; CYTOKERATIN 10; PLACENTA PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANALYSIS; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PLACENTA; PLACENTA DEVELOPMENT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREECLAMPSIA; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TISSUE HOMOGENATE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 33745745286     PISSN: 16154053     EISSN: 16154061     Source Type: Journal    
DOI: 10.1002/sita.200500072     Document Type: Article

References (35)

1. McCornick, M. C. (1985) The contribution of low birth weight to infant mortality and childhood morbidity. N. Engl. J. Med. 312: 82-90.
2. Rath, W., Faridi, A., Dudenhausen, J. W. (2000) HELLP syndrome. J. Perinat. Med. 28: 249-260.
3. Maynard, S. E., Min, J. Y., Merchan, J., Lim, K. H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., Epstein, F. H., Sukhatme, V. P., Karumanchi, S. A. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111: 649-658.
4. Kendall, R. L., Wang, G., Thomas, K. A. (1996) Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun. 226: 324-328.
5. Shibuya, M. (2001) Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct. Funct. 26: 25-35.
6. Su, Y., Lee, C. N., Cheng, W. F., Shau, W. Y., Chow, S. N., Hsieh, F. J. (2001) Decreased Maternal Serum Placenta Growth Factor in Early Second Trimester and Preeclampsia. Obstet. Gynecol. 97: 898-904.
7. Lee, M. H., Park, J.-W. (1995) Lipid peroxidation products mediate damage of superoxide dismutase. Biochem. Mol. Biol. Int. 35: 1093-1102.
8. Hass, R., Sohn, C. (2003) Increased oxidative stress in preeclamptic placenta is associated with altered proteasome activity and protein patterns. Placenta 24: 979-984.
9. Pang, Z. J., Xing, F. Q. (2003) Comparative study on the expression of cytokine - receptor genes in normal and preeclamptic human placentas using DNA microarrays. J. Perinatal Med. 31:153-162.
10. Lala, P. K., Chakraborty, C. (2003) Factors Regulating Trophoblast Migration and Invasiveness: Possible Derangements Contributing to Pre-eclampsia and Fetal Injury. Placenta 24: 575-587.
11. Walsh, S. W. (1998) Maternal-Placental Interactions of oxidative stress and antioxidants in preeclampsia. Sem. Reprod. Endocrinol. 16: 93-104.
12. Lowe, D. T. (2000) Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 4: 441-458.
13. Baker, P. N., Davidge, S. T., Roberts, J. M. (1995) Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension 26: 244-248.
14. McKinney, E. T., Shouri, R., Hunt, R. S., Ahokas, R. A., Sibai, B. M. (2000) Plasma, urinary, and salivary 8-epiprostaglandin f2alpha levels in normotensive and preeclamptic pregnancies. Am. J. Obste. Gynecol. 183: 874-877.
15. Walsh, S. W., Vaughan, J. E., Wang, Y., Roberts, L. J. (2000) Placental isoprostane is significantly increased in preeclampsia. FASEB J. 14: 1289-1296.
16. Diederich, F., Renner, A., Rath, W., Kuhn, W., Wieland, E. (2001) Lipid hydroperoxides and free radical scavenging enzyme activities in preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: no evidence for circulating primary products of lipid peroxidation. Am. J. Obstet. Gynecol. 185: 166-172.
17. Conde-Agudelo, A., Villar, J., Lindheimer, M. (2004) World Health Organization Systematic Review of Screening Tests for Preeclampsia. Obstet. Gynecol. 104: 1367-1391.
18. Witlin, A. G., Sibai, B. M. (1997) Hypertension in pregnancy: Current Concepts of Preeclampsia. Annu. Rev. Med. 48: 115-127.
19. Nelson, R. W., McLean, M. A., Hutchens, T. W. (1994) Quantitative determination of proteins by matrix-assisted laser-desorption ionizing time-of-flight mass spectrometry. Anal. Chem. 66: 1408-1415.
20. Van Muijen, G. N., Warnaar, S. O., Ponec, M. (1987) Differentiation- related changes of cytokeratin expression in cultured keratinocytes and in fetal, newborn, and adult epidermis. Exp. Cell Res. 171: 331-345.
21. Service, R. F. (1998) New role for estrogen in cancer? Science 279: 1631-1633.
22. Hass, R., von Wasielewski, R., Fazekas, U., Bartels, H., Jans, E., Lück, H. J. (2005) Dual signaling mechanisms of estrogen: Phosphorylation of P53 at Ser15 in aging HMEC in the absence of estrogen receptor. Signal Transduction 5: 40-47.
23. Ockleford, C. D., Smith, R. K., Byrne, S., Sanders, R., Bosio, P. (2004) Confocal laser scanning microscope study of cytokeratin immunofluorescence differences between villous and extravillous trophoblast: cytokeratin downregulation in pre-eclampsia. Microsc. Res. Tech, 64: 43-53.
24. Moll, R. (1993) Cytokeratins as marker of differentiation: expression profiles in epithelia and epithelial tumors. In: Progress in Pathology. Ed. G. Seifert, Gustav Fischer Verlag, Stuttgart (Germany), pp. 1-41.
25. Hesse, M., Franz, T., Tamai, Y., Taketo, M. M., Magin, T. M. (2000) Targeted deletion of keratins 18 and 19 leads to trophoblast fragility and early embryonic lethality. EMBO J. 19: 5060-5070.
26. Maytin, E. V., Lin, J. C., Krishnamurthy, R., Batchvarova, N., Ron, D., Mitchell, P. J., Habener, J. F. (1999) Keratin 10 gene expression during differentiation of mouse epidermis requires transcription factors C/Ebp and Ap-2. Dev. Biol. 216: 164-181.
27. Santos, M., Perez, P., Segrelles, C., Ruiz, S., Jorcano, J. L., Paramio, J. M. (2003) Impaired NF-κB activation and increased production of tumor necrosis factor alpha in transgenic mice expressing keratin K10 in the basal layer of the epidermis. J. Biol. Chem. 278: 13422-13430.
28. Reichelt, J., Bauer, C., Porter, R., Lane, E., Magin, T. M. (1997) Out of balance: consequences of a partial keratin 10 knockout. J. Cell Sci. 110: 2175-2186.
29. Reichelt, J., Magin, T. M. (2002) Hyperproliferation, induction of c-Myc and 14-3-3σ, but no cell fragility in keratin-10-null mice. J. Cell Sci. 115: 2639-2650.
30. Porter, R. M., Leitgeb, S., Melton, D. W., Swensson, O., Eady, R. A., Magin, T. M. (1996) Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis. J. Cell Biol. 132: 925-936.
31. Reichelt, J., Bussow, H., Grund, C., Magin, T. M. (2001) Formation of a normal epidermis supported by increased stability of keratins 5 and 14 in keratin 10 null mice. Mol. Biol. Cell 12: 1557-1568.
32. Redman, C. W. G., Sargent, I. L. (2003) Pre-eclampsia, the placenta and the maternal systemic inflammatory response - a review. Placenta 24: 21-27.
33. Patrussi, L., Baldari, C. T. (2004) Positive and negative regulators of Ras in T cells. Signal Transduction 4: 9-16.
34. Simm, A., Brömme, H. J. (2005) Reactive oxygen species (ROS) and aging: Do we need them - can we measure them - should we block them? Signal Transduction 5: 115-125.
35. Hass, R. (2005) Retrodifferentiation and reversibility of aging: forever young? Signal Transduction 5: 40-47.